| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 129,395 | 125,804 | 121,955 | 140,354 | | Cost of Revenue | 22,942 | 99,541 | 80,720 | 131,174 | | | Gross Profit | 106,453 | 26,263 | 41,235 | 9,180 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 87,241 | 5,902 | 21,022 | (13,863) | | Non Recurring |
-
| (528) | (471) | (225) | | Others | 13,272 | 13,386 | 13,433 | 13,001 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,536 | 7,503 | 7,251 | 10,267 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,544) | 30 | 33 | 32 | | Earnings Before Interest And Taxes | 6,587 | 7,649 | 7,168 | 10,101 | | Interest Expense | 35 | 34 | 64 | 110 | | Income Before Tax | 6,552 | 7,615 | 7,104 | 9,991 | | Income Tax Expense | 2,987 | 2,877 | 3,051 | 4,169 | | Minority Interest | (93) | (145) | (116) | (198) | | | | Net Income From Continuing Ops | 3,472 | 4,477 | 4,053 | 5,822 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,472 | 4,477 | 4,053 | 5,822 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,472 | $4,477 | $4,053 | $5,822 |
|
0.02% Nasdaq 0.00%
Income Statement
